Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Luliberin | - |
Sus scrofa | |
neurotensin | - |
Sus scrofa | |
Thyroliberin analogues | LLD-thyroliberin, pyroglutamyl-His-Pro-NHCH3, pyroglutamyl-His-Pro-Gly-NHCH3, pyroglutamyl-Phe-Pro-NH2 | Sus scrofa |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.056 | - |
Thyroliberin | - |
Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
serum | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | no hydrolysis of pyroglutamyl-His | Sus scrofa | ? | - |
? | |
additional information | no hydrolysis of pyroglutamyl-Ala or pyroglutamyl 2-naphthylamide (known substrates of the serum enzyme) | Sus scrofa | ? | - |
? | |
additional information | no hydrolysis of neurotensin | Sus scrofa | ? | - |
? | |
additional information | no hydrolysis of thyroliberin analogues LLD-thyroliberin, pyroglutamyl-His-Pro-NHCH3, pyroglutamyl-His-Pro-Gly-NHCH3 or pyroglutamyl-Phe-Pro-NH2 | Sus scrofa | ? | - |
? | |
additional information | no hydrolysis of luliberin | Sus scrofa | ? | - |
? | |
thyroliberin + H2O | rapid stereospecific cleavage only of the pyroglutamyl-histidine bond of thyroliberin and closely related peptides | Sus scrofa | pyroglutamic acid + His-Pro-NH2 | - |
? |